What is DCF analysis?

DCF (Discounted Cash Flow) analysis estimates the intrinsic value of a company by projecting future free cash flows and discounting them to present value using the weighted average cost of capital (WACC). It is one of the most widely used valuation methods in investment banking and equity research.

How accurate is DCF valuation?

DCF accuracy depends on the quality of assumptions including growth rates, discount rates, and terminal value estimates. DeepViews uses real SEC financial data and market-derived WACC to improve reliability. Sensitivity analysis helps quantify the range of possible outcomes.

What discount rate should I use for DCF?

The discount rate is typically the company's Weighted Average Cost of Capital (WACC), which accounts for the cost of equity (calculated via CAPM) and cost of debt, weighted by the company's capital structure. Most established companies have WACC between 6% and 12%.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) — DCF Valuation Summary

Based on a DCF model, GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) has an estimated fair value of $32.37, compared to a current price of $51.61.

Model Assumptions & Verdict

Using a WACC of 8.6%, a terminal growth rate of 2.5%, and projected FCF growth of -10.0%, the model suggests GSK is currently overvalued with a margin of safety of -37.3%.

Verdict: Overvalued — Margin of Safety: -37.3%

VALUATION

DCF Valuation Calculator

DCF Calculator

This DCF calculator auto-populates financial data from SEC EDGAR XBRL filings. All assumptions are adjustable. Results update in real-time as you change inputs.

[01]

Enter Company Ticker

Quick search:

Model Inputs & Results

[02]DCF Assumptions

Valuation Basis

Growth Stage

Rate declines linearly to terminal rate over projection period

Growth Stage Duration

Free Cash Flow$0

Negative or zero FCF — DCF model is not applicable. Enter a positive value or use alternative valuation methods.

Growth Stage Rate10.0%

-10%40%

Terminal Stage

Perpetuity growth after projection period

Terminal Stage Rate2.5%

0%5%

WACC (Discount Rate)10.0%

4%20%

Net Debt$0

Shares Outstanding0.00B

Include Tangible Book Value

Search for a company to start DCF analysis

Enter a ticker symbol and data will auto-populate into the model

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.